Tech
4.6
Isomorphic Labs' high valuation signals AI's growing role in drug development
Published 16 min ago1 sourceEvidence: Reported
SeverityModerateSTAT NewsLow-rated sourceUS · GB
Zagreb-based vitaLABS is developing VB-7, a molecule aimed at healthier aging in dogs, with formulations at the core of the project. The development is at an early stage, with no clinical data or timeline disclosed. This is a niche veterinary biotech development with limited immediate market or geopolitical impact.
Published 16 min ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 2 h ago2 sourcesEvidence: Reported
Published 1 d ago2 sourcesEvidence: Unknown
Published 23 h ago2 sourcesEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago2 sourcesEvidence: Unknown
Published 1 d ago1 sourceEvidence: Reported